Odyssey Therapeutics reported earnings of -$ 1.10 per ODTX share on Nov 4, 2026, beating analysts' expectations by
| Report Date | Nov 4, 2026 |
|---|---|
| Forecasted EPS | -$ 1.07 |
| Earnings Per Share (Surprise) | -$ 1.10 (-$ 0.03) |
Out of the last 3 earnings reporting periods, Odyssey Therapeutics beat analysts’ expectations 0 times and fell short of expectations 3 time(s). Odyssey Therapeutics reported earnings per share of -$ 1.10 in the last report falling to reach an estimated EPS of -$ 1.07 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 1.07 | -$ 1.10 | - | - |
| Aug 4, 2026 | -$ 1.61 | -$ 1.74 | - | - |
| Jun 17, 2026 | -$ 1.11 | -$ 6.77 | - | - |
Odyssey Therapeutics’s stock was trading at $ 21.57 on Nov 3, 2026 a day before the last earnings report was released.Following the release of the earnings report, ODTX’s price decreased to $ 18.88 on Nov 5, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 1.10 | $ 21.57 | $ 18.88 | |
| Aug 4, 2026 | -$ 1.74 | $ 18.13 | $ 20.89 | |
| Jun 17, 2026 | -$ 6.77 | $ 17.87 | $ 19.07 |
Odyssey Therapeutics released its most recent earnings reports in November 2026, August 2026, June 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Odyssey Therapeutics missed analysts’ expectations during the last earnings period by
